LCM
HRMY icon

Legato Capital Management’s Harmony Biosciences HRMY Stock Holding History

Legato Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$780K Buy
+21,409
New +$675K 0.06% 426
2026
Q1 		– Sell
-26,391
Closed -$988K – 805
2025
Q4 		$988K Sell
26,391
-25,024
-49% -$823K 0.09% 361
2025
Q3 		$1.42M Buy
51,415
+19,504
+61% +$672K 0.15% 205
2025
Q2 		$1.01M Hold
31,911
– – 0.12% 275
2025
Q1 		$1.06M Buy
31,911
+5,191
+19% +$186K 0.14% 233
2024
Q4 		$919K Buy
26,720
+5,506
+26% +$189K 0.12% 315
2024
Q3 		$849K Buy
+21,214
New +$745K 0.1% 349
2023
Q3 		– Sell
-5,870
Closed -$207K – 583
2023
Q2 		$207K Buy
+5,870
New +$203K 0.03% 517

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legato Capital Management's HRMY Position: Q2 2026 in Review

Legato Capital Management opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 21,409 shares worth $780K. The stake represents 0.06% of the portfolio and ranks #426 among its holdings. This is a return to the name: Legato Capital Management previously reported a position in HRMY as recently as Q4 2025.

Legato Capital Management first reported a position in HRMY in Q2 2023 and has held it in 8 quarters since. The position peaked at $1.42M in Q3 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Legato Capital Management held 21,409 shares of Harmony Biosciences worth $780K as of Q2 2026.
  • Harmony Biosciences was a new Legato Capital Management position in Q2 2026.
  • Harmony Biosciences made up 0.06% of Legato Capital Management's portfolio in Q2 2026, its #426 holding.
  • Legato Capital Management first reported a position in Harmony Biosciences in Q2 2023 and has held it in 8 quarters since.
  • Legato Capital Management's Harmony Biosciences position peaked at $1.42M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.